50 related articles for article (PubMed ID: 16892011)
1. Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder.
Yin W; Chen N; Zhang Y; Zeng H; Chen X; He Y; Wang X; Zhou Q
Mod Pathol; 2006 Nov; 19(11):1487-97. PubMed ID: 16892011
[TBL] [Abstract][Full Text] [Related]
2. DDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: a large cohort study.
Tsai MC; Li WM; Huang CN; Ke HL; Li CC; Yeh HC; Chan TC; Liang PI; Yeh BW; Wu WJ; Lim SW; Li CF
Oncotarget; 2016 Nov; 7(48):78918-78931. PubMed ID: 27793038
[TBL] [Abstract][Full Text] [Related]
3. The expression of beta human chorionic gonadotrophin (β-HCG) in human urothelial carcinoma.
Venyo AK; Herring D; Greenwood H; Maloney DJ
Pan Afr Med J; 2010; 7():20. PubMed ID: 21918707
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of survivin in G2/M cells and inhibition of caspase 9 activity enhances resistance in staurosporine-induced apoptosis.
Chandele A; Prasad V; Jagtap JC; Shukla R; Shastry PR
Neoplasia; 2004; 6(1):29-40. PubMed ID: 15068669
[TBL] [Abstract][Full Text] [Related]
5. Expression of IAP family proteins in colon cancers from patients with different age groups.
Endo T; Abe S; Seidlar HB; Nagaoka S; Takemura T; Utsuyama M; Kitagawa M; Hirokawa K
Cancer Immunol Immunother; 2004 Sep; 53(9):770-6. PubMed ID: 15138717
[TBL] [Abstract][Full Text] [Related]
6. XAF1 as a prognostic biomarker and therapeutic target in pancreatic cancer.
Huang J; Yao WY; Zhu Q; Tu SP; Yuan F; Wang HF; Zhang YP; Yuan YZ
Cancer Sci; 2010 Feb; 101(2):559-67. PubMed ID: 19922503
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Inhibitor of Apoptosis Protein Expression and Prognostic Significance in Non-Small Cell Lung Cancer.
Liu J; Lu Y; Huang W; He Z
Front Genet; 2021; 12():764270. PubMed ID: 34925455
[TBL] [Abstract][Full Text] [Related]
8. Survivin and gliomas: A literature review.
Varughese RK; Torp SH
Oncol Lett; 2016 Sep; 12(3):1679-1686. PubMed ID: 27588117
[TBL] [Abstract][Full Text] [Related]
9. Survivin (BIRC5): Implications in cancer therapy.
Siragusa G; Tomasello L; Giordano C; Pizzolanti G
Life Sci; 2024 Jun; 350():122788. PubMed ID: 38848940
[TBL] [Abstract][Full Text] [Related]
10. [Mimickers and diagnostic pitfalls of urinary bladder cancer].
Lindemann-Docter K; Gaisa NT
Pathologie (Heidelb); 2024 May; ():. PubMed ID: 38816588
[TBL] [Abstract][Full Text] [Related]
11. Investigation of Ki67 and Phospho-Histone H3 Expressions in Urothelial Carcinoma of the Bladder by Immunohistochemical Method.
Yüceer RO; Başpınar Ş
Cureus; 2024 Feb; 16(2):e55297. PubMed ID: 38558732
[TBL] [Abstract][Full Text] [Related]
12. Hispolon Methyl Ether, a Hispolon Analog, Suppresses the SRC/STAT3/Survivin Signaling Axis to Induce Cytotoxicity in Human Urinary Bladder Transitional Carcinoma Cell Lines.
Kuo MY; Yang WT; Ho YJ; Chang GM; Chang HH; Hsu CY; Chang CC; Chen YH
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613579
[TBL] [Abstract][Full Text] [Related]
13. Livin promotes tumor progression through YAP activation in ovarian cancer.
Gao J; Han W; He Y; Zhou J; Miao J; Zhang G
Am J Cancer Res; 2020; 10(10):3179-3193. PubMed ID: 33163264
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of miR-199a-5p promotes prostate adeno-carcinoma progression through loss of its inhibition of HIF-1α.
Zhong J; Huang R; Su Z; Zhang M; Xu M; Gong J; Chen N; Zeng H; Chen X; Zhou Q
Oncotarget; 2017 Oct; 8(48):83523-83538. PubMed ID: 29137361
[TBL] [Abstract][Full Text] [Related]
15. High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved.
Luo Y; Zhang X; Mo M; Tan Z; Huang L; Zhou H; Wang C; Wei F; Qiu X; He R; Chen G
Medicine (Baltimore); 2016 Apr; 95(15):e3337. PubMed ID: 27082587
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of survivin, β-catenin and p53 expression in urothelial carcinoma.
Senol S; Yildirim A; Ceyran B; Uruc F; Zemheri E; Ozkanli S; Akalin I; Ulus I; Caskurlu T; Aydin A
Bosn J Basic Med Sci; 2015 Aug; 15(4):7-14. PubMed ID: 26614845
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-mesenchymal transformation markers E-cadherin and survivin predict progression of stage pTa urothelial bladder carcinoma.
Breyer J; Gierth M; Shalekenov S; Aziz A; Schäfer J; Burger M; Denzinger S; Hofstädter F; Giedl C; Otto W
World J Urol; 2016 May; 34(5):709-16. PubMed ID: 26394624
[TBL] [Abstract][Full Text] [Related]
18. Ectopic expression of AP-2α transcription factor suppresses glioma progression.
Su W; Xia J; Chen X; Xu M; Nie L; Chen N; Gong J; Li X; Zhou Q
Int J Clin Exp Pathol; 2014; 7(12):8666-74. PubMed ID: 25674231
[TBL] [Abstract][Full Text] [Related]
19. Expression of survivin in squamous cell carcinoma and transitional cell carcinoma of the urinary bladder: a comparative immunohistochemical study.
Makboul R; Refaiy AE; Badary FA; Abdelkawi IF; Merseburger AS; Mohammed RA
Korean J Urol; 2015 Jan; 56(1):31-40. PubMed ID: 25598934
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
